Skip to main content

Table 2 Plasma levels of LCN2, MMP9 and MMP9/LCN2 complex in nAMD and controls

From: Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis

Variable (ng/ml) Control (Mean ± SD) nAMD (Mean ± SD) Univariate analysis (p value) Corrected by age (p value) Corrected by taking aspirin (p value) Corrected by taking aspirin and age
  N = 43 N = 168     
LCN2 153.24 ± 49.55 181.46 ± 73.62 0.047a  0.259b 0.602c 0.396d
  N = 43 N = 167     
MMP9 124.16 ± 63.12 116.36 ± 68.45 0.274a    
  N = 43 N = 167     
MMP9/LCN2 188.38 ± 45.12 179.16 ± 58.11 0.335a    
  1. aIndependent samples t test
  2. bUnivariate analysis corrected for age
  3. cUnivariate analysis corrected for taking aspirin
  4. dUnivariate analysis corrected for age and taking aspirin